Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dedifferentiated clear cell chondrosarcoma.

R K Kalil1, C Y Inwards, K K Unni

  • 1Division of Anatomic Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

The American Journal of Surgical Pathology
|August 10, 2000
PubMed
Summary

Dedifferentiation, a rare aggressive change in chondrosarcomas, is now described in clear cell chondrosarcoma. This study details three cases showing dedifferentiation at diagnosis, recurrence, or metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESMO open·2025
Same author

Imaging features of intraosseous hemangiomas: beyond the mobile spine and calvarium.

Skeletal radiology·2023
Same author

A systematic review of contemporary phase I trials in patients with lymphoma.

Critical reviews in oncology/hematology·2022
Same author

Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2021
Same author

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Leukemia·2016

Area of Science:

  • Oncology
  • Pathology
  • Skeletal Tumors

Background:

  • Dedifferentiation transforms low-grade chondrosarcomas into aggressive tumors.
  • Clear cell chondrosarcoma is a rare, low-grade cartilaginous tumor typically curable by resection.
  • Dedifferentiation has not been previously documented in clear cell chondrosarcoma.

Observation:

  • Three patients initially diagnosed with clear cell chondrosarcoma of the femur were studied.
  • Two patients underwent resection; one developed local recurrence with undifferentiated sarcoma, and the other had metastases.
  • The third patient presented with dedifferentiated clear cell chondrosarcoma at initial resection.

Findings:

  • This study reports the first known cases of dedifferentiation occurring in clear cell chondrosarcoma.

Related Experiment Videos

  • Dedifferentiation manifested at initial diagnosis, recurrence, and metastasis in the three patients.
  • All three patients with dedifferentiated clear cell chondrosarcoma died with metastatic disease.

    • Implications:

    • The findings suggest clear cell chondrosarcoma can undergo dedifferentiation, leading to aggressive behavior.
    • This highlights the importance of recognizing dedifferentiation in clear cell chondrosarcoma for prognostic and therapeutic considerations.
    • Further research is needed to understand the mechanisms and clinical implications of dedifferentiation in this rare tumor type.